Literature DB >> 10171117

The inhibition of bacterial adhesion to a tobramycin-impregnated polymethylmethacrylate substratum.

M Oga1, T Arizono, Y Sugioka, P T Naylor, Q N Myrvik, A G Gristina.   

Abstract

Tobramycin sulfate powder (1.2 g) was mixed with Palacos polymethylmethacrylate (PMMA) bone cement (40 g) to produce 100 discs containing 5.9 mg tobramycin per disc. These discs were used to evaluate the inhibition of bacterial adhesion to an antibiotic-laden biomaterial. Tobramycin-impregnated PMMA discs and control discs containing no tobramycin were exposed in vitro to Staphylococcus epidermidis. Colonization was quantitated using plate count techniques and electron microscopy. Tobramycin-impregnated surfaces reduced adhesive bacteria colonization by 1 log relative to control discs. These observations suggest that tobramycin-impregnated PMMA may not be significantly effective in preventing colonization of the biomaterial substratum and PMMA may be a poor choice as a drug delivery vehicle in biomaterial and compromised tissue-centered infections.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 10171117

Source DB:  PubMed          Journal:  J Long Term Eff Med Implants        ISSN: 1050-6934


  3 in total

1.  The relationship between inhibition of bacterial adhesion to a solid surface by sub-MICs of antibiotics and subsequent development of a biofilm.

Authors:  Nuno Cerca; Silvia Martins; Gerald B Pier; Rosário Oliveira; Joana Azeredo
Journal:  Res Microbiol       Date:  2005-03-17       Impact factor: 3.992

2.  The effects of farnesol on Staphylococcus aureus biofilms and osteoblasts. An in vitro study.

Authors:  Aasis Unnanuntana; Lindsay Bonsignore; Mark E Shirtliff; Edward M Greenfield
Journal:  J Bone Joint Surg Am       Date:  2009-11       Impact factor: 5.284

3.  Treatment of Pseudomonas aeruginosa Biofilm Present in Endotracheal Tubes by Poly-l-Lysine.

Authors:  Mustapha Si-Tahar; Virginie Hervé; Antoine Guillon; Delphine Fouquenet; Eric Morello; Clémence Henry; Sonia Georgeault
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.